Skip to main content

Satellos Bioscience Inc.

MSLE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001421642

No open-market purchases or sales by Satellos Bioscience Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $59.6M in total; no superinvestor holds it.

Superinvestors holding MSLE, Q2 2026

See all superinvestors

No superinvestor reported holding MSLE in Q2 2026.